Anna Mueller, MD, Mount Sinai, presented the findings at the American College of Cardiology 2025 Annual Scientific Session ...

The “neutral” trial, troubled by the COVID-19 pandemic, found that intensive medical therapy didn’t lower events in INOCA.

GEHC's latest commercial launch of Flyrcado and the grant of pass-through status by CMS aim to serve a wider patient pool across the United States.

Having a coronary artery calcium (CAC) score of zero has generally been accepted as a marker of a very low risk of having a ...

Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is safer and more effective ...

For decades, the clinical approach to coronary artery disease has been centred on the acute effects of coronary occlusion and ...

For decades, the management of coronary artery disease has focused on epicardial obstruction and ischaemia, which is often recognised too late for long-term intervention. This approach limits the ...

BACKGROUND: Shared genetic and lifestyle risk factors may underlie the development of both coronary artery disease (CAD) and ...

GE HealthCare has raised the curtain on a new CT system with features designed specifically for addressing cardiovascular ...

Coronary artery disease (CAD), better known as clogged arteries, is the leading cause of death in the United States, ...

The following is a summary of “National Trends in Central Retinal Artery Occlusion Presentations and Stroke Workup in United ...